Elena B. Sgarbossa - Concepedia

Author

Elena B. Sgarbossa

Also Known As

E B Sgarbossa, E Sgarbossa, E. Sgarbossa, ELENA B. SGARBOSSA, ELENA SGARBOSSA, Elena B Sgarbossa, Elena B. Sgarbossa, Elena Sgarbossa

Publications

Citations

H-Index

Concepts

All Affiliations

Cleveland Clinic Rush University Medical Center Duke Medical Center Clinical Research Institute Cleveland Foundation

About

Elena B. Sgarbossa is an author at Cleveland Clinic specializing in cardiology, medicine, and emergency medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	874
2	Emergency Medicine	13	17	718
3	Public Health	10	10	399
4	Nursing	1	1	37
5	Geriatrics	1	1	37

Elena B. Sgarbossa

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Electrocardiographic Diagnosis of Evolving Acute Myocardial Infarction in the Presence of Left Bundle-Branch Block Elena B. Sgarbossa, Sergio L. Pinski, Alejandro Barbagelata, New England Journal of Medicine	1996	685
Quality of Life and Clinical Outcomes in Elderly Patients Treated with Ventricular Pacing as Compared with Dual-Chamber Pacing Gervasio A. Lamas, E. John Orav, Bruce S. Stambler, New England Journal of Medicine	1998	625
Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities. Elena B. Sgarbossa, Sergio L. Pinski, James D. Maloney, Circulation	1993	205
Early electrocardiographic diagnosis of acute myocardial infarction in the presence of ventricular paced rhythm Elena B. Sgarbossa, Sergio L. Pinski, Kathy Gates, The American Journal of Cardiology Electrophysiological EvaluationCardiovascular DiseaseMyocardial InfarctionElectrophysiologyAcute Myocardial Infarction	1996	157
Acute Myocardial Infarction and Complete Bundle Branch Block at Hospital Admission: Clinical Characteristics and Outcome in the Thrombolytic Era fn1fn1This study was supported by grants from Bayer Corporation, New York, New York; Genentech, Inc., South San Francisco, California; CIBA-Corning, Medford, Massachusetts; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France. Elena B. Sgarbossa, Sergio L. Pinski, Eric J. Topol, Journal of the American College of Cardiology ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseHospital AdmissionPharmacotherapy	1998	155
Non–Q-Wave Versus Q-Wave Myocardial Infarction After Thrombolytic Therapy Shaun G. Goodman, Anatoly Langer, Allan M. Ross, Circulation	1998	71
The left bundle-branch block puzzle in the 2013 ST-elevation myocardial infarction guideline: From falsely declaring emergency to denying reperfusion in a high-risk population. Are the Sgarbossa Criteria ready for prime time? Qiangjun Cai, Nilay Mehta, Elena B. Sgarbossa, American Heart Journal ThrombosisSgarbossa Criteria ReadyCardiovascular DiseaseCoronary UnitMyocardial Infarction	2013	70
The Role of Pacing Modality in Determining Long-Term Survival in the Sick Sinus Syndrome Elena B. Sgarbossa Annals of Internal Medicine	1993	57
Incidence and Predictors of Syncope in Paced Patients with Sick Sinus Syndrome Elena B. Sgarbossa, Sergio L. Pinski, Fredrick Jaeger, Pacing and Clinical Electrophysiology	1992	55
Clinical characteristics of patients intolerant to VVIR pacing Kenneth A. Ellenbogen, Bruce S. Stambler, E. John Orav, The American Journal of Cardiology Vvir PacingElectrophysiological EvaluationHeart FailureDevice TherapyPatient Safety	2000	50

Page 1